Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.

Mori, Keiichiro

Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis. [electronic resource] - Prostate cancer and prostatic diseases 12 2020 - 539-548 p. digital

Publication Type: Journal Article; Meta-Analysis; Systematic Review

1476-5608

10.1038/s41391-020-0222-6 doi


Androgen Antagonists--administration & dosage
Androstenes--administration & dosage
Benzamides--administration & dosage
Clinical Trials, Phase II as Topic
Disease Progression
Drug Administration Schedule
Humans
Kallikreins--blood
Male
Nitriles--administration & dosage
Phenylthiohydantoin--administration & dosage
Prostate-Specific Antigen--blood
Prostatic Neoplasms, Castration-Resistant--blood
Randomized Controlled Trials as Topic
Survival Rate
Treatment Outcome